ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
5,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,2,Deafness,Hearing losses,Hearing disorders,Ear,N
7,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
8,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
9,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
10,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
11,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
12,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
13,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
13,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
13,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,Y
15,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
17,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
19,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,1,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
24,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
25,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
25,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
28,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
29,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
29,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
30,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
32,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
34,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,Y
35,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
36,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
37,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
38,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
39,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
40,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
40,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
41,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
42,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
43,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
44,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
45,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Myopathy,Myopathies,Muscle disorders,Musc,N
47,1,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
48,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
49,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
49,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
50,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
50,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
51,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
51,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
51,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
51,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
52,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
52,2,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
52,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
52,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
52,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
53,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
53,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
55,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
55,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
56,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
56,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
58,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
59,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
59,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
59,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
60,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
61,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
62,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
62,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
63,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,3,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
64,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
64,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
64,3,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
66,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
67,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
67,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
68,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
68,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
70,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
70,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
71,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
71,2,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
72,1,Acquired hydrocele,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
72,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
73,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
73,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
74,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
74,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
75,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
76,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
77,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
77,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
78,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
80,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
82,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
82,2,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
83,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
84,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
85,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
86,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
87,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
87,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
87,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
88,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
89,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
89,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
90,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
91,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
92,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
92,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
93,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
94,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
94,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
94,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
95,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
96,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
96,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
97,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
97,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
98,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,2,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
98,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
99,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
99,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
100,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
101,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
101,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
102,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
103,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
104,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
105,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
106,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
107,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
108,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
108,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
109,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
110,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
112,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
112,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
113,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
114,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
115,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
115,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,Y
115,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
116,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
116,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
118,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
119,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
120,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
120,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
121,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
122,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
123,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
124,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
125,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
126,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
127,1,Ewing's sarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
128,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
129,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
130,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
131,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
132,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
133,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
134,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
135,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
136,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
136,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
137,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
138,1,Nephroblastoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
139,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
140,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
141,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
141,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
142,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
142,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
143,1,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
144,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
144,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
144,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
144,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
144,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
144,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
145,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
145,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
145,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
145,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
145,5,Nosophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
145,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
145,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
146,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
147,1,Deafness,Hearing losses,Hearing disorders,Ear,N
148,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
148,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
148,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
149,1,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
149,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
149,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
150,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
151,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
152,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
152,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
153,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
153,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
153,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
154,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
155,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
156,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
157,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
158,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
158,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
158,4,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
159,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
160,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
161,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
162,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
162,2,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
163,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
164,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
164,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
164,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
164,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
164,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
165,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
166,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
167,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
167,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
168,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
168,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
169,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
170,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
170,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
170,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
170,6,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
170,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
170,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
170,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
170,10,Toxic shock syndrome,Infections NEC,Infections - pathogen unspecified,Infec,N
170,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
172,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
173,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
174,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
175,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
176,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
176,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
177,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
177,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
178,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
179,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
180,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
180,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
180,3,Neuromuscular block prolonged,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
181,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
181,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
181,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
182,1,Deafness,Hearing losses,Hearing disorders,Ear,N
183,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
184,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
184,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
185,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
185,2,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
185,3,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
185,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
187,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
188,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
190,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
190,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
191,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
191,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
191,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
191,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
192,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
193,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
193,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
194,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
195,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
195,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
195,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
195,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
195,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
195,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
196,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
196,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
196,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
197,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
198,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
198,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
199,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
199,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
200,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
201,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
202,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
202,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
203,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
204,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
205,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
205,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
206,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
206,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
207,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
207,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,Y
208,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
209,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
210,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,Y
211,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
212,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
213,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
214,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
214,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
215,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
215,2,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
215,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
215,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
216,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
217,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
218,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
219,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
220,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
220,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
220,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
221,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
221,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
221,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
221,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
222,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
222,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
223,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
224,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
225,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
225,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
225,3,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
225,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
225,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
226,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
226,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
227,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
228,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
229,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
230,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
231,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
231,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
231,3,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
231,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
231,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
231,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
232,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
232,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
232,3,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
233,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
233,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
234,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
234,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
234,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
234,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
234,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
234,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
234,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
234,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
235,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
235,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
235,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
235,4,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
236,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
236,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
236,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
236,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
237,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
238,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
238,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
238,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
239,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
239,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
239,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
240,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
241,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
241,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
241,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
241,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
241,5,Lymph node abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
241,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
241,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
242,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
243,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
244,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
244,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
244,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
244,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
245,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
245,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
246,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
247,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
248,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
250,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
251,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
251,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
252,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
252,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
252,4,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
252,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
252,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
252,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
252,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
253,1,Migraine,Migraine headaches,Headaches,Nerv,N
254,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
254,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
255,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
255,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
256,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
256,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
257,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
258,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
259,1,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,Y
260,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
261,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
262,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
262,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
262,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
262,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
263,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
264,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
264,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
265,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
265,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
266,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
266,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
266,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
266,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
266,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
266,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
267,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
267,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
267,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
268,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
268,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
269,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
269,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
269,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
270,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
271,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
272,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
272,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
272,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
273,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
273,2,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
273,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
273,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
273,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
273,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
274,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
275,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
275,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
276,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
276,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
276,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
276,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
276,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
276,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
276,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
277,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
278,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
278,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
278,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
279,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
279,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
279,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
279,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
279,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
279,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
280,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
281,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
281,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
282,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
282,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
282,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
282,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
282,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
282,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
283,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
283,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
283,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
283,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
283,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
283,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
284,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
284,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
284,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
284,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
284,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
284,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
285,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
287,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
287,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
288,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
288,2,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
288,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
288,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
289,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
289,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
290,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
291,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
292,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
293,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
294,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
295,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
296,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
297,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
297,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
297,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
298,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
298,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
298,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
299,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
300,1,Deafness,Hearing losses,Hearing disorders,Ear,N
300,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
301,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
302,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
303,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
304,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
304,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
305,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
305,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
306,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
306,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
307,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
308,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
309,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
310,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
311,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
311,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
312,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
313,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
314,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
314,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
314,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
315,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
316,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
316,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
316,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
316,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
316,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
317,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
317,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
317,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
317,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
317,5,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
317,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
318,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
318,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
318,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
318,4,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
319,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
319,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
319,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
319,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
320,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
320,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
320,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
320,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
321,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
321,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
321,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
321,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
321,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
322,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
323,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
324,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
324,2,Headache,Headaches NEC,Headaches,Nerv,N
324,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
325,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
326,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
327,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
328,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
329,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
329,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
330,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
331,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
332,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
333,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
334,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
335,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
336,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
336,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
337,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
337,2,Headache,Headaches NEC,Headaches,Nerv,N
337,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
338,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
339,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
339,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
339,3,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
339,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
340,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
341,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
341,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
341,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
341,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
342,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
343,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
344,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
344,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
345,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
345,2,Congenital herpes simplex infection,Viral infections congenital,Infections and infestations congenital,Cong,N
345,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
345,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
346,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
346,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
346,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
346,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,5,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
347,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
347,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
347,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
347,4,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
347,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
347,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
347,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
348,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
348,2,Congenital neuropathy,Peripheral nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
349,1,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
350,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
350,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
350,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
350,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
350,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
351,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
352,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
353,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
354,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
354,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
354,3,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
354,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
354,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
354,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
354,7,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
354,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
354,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
354,10,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
354,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,14,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
354,15,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
354,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
354,17,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
355,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
356,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
356,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
356,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
356,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
357,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
357,2,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
358,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
358,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
358,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
359,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
360,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
360,2,Nephroblastoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
361,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
361,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
361,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
361,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
361,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
362,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
362,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
362,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
362,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
362,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
362,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
362,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
362,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
362,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
362,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
362,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
362,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
362,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
362,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
362,15,Tic,Tic disorders,Changes in physical activity,Psych,N
363,1,Bladder fibrosis,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
363,2,Catheterisation venous,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
363,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
363,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
363,5,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
363,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
363,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
364,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
366,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
366,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
366,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
366,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
366,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
366,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
366,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
366,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
366,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
366,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
367,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
367,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
368,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
369,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
370,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
371,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
371,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
371,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
371,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
371,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
371,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
371,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
372,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
372,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
373,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
373,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
373,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
373,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
374,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
374,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
374,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
375,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
376,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
376,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
376,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
377,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
377,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
377,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
378,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,2,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
378,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
378,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
379,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
379,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
380,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
380,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
380,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
380,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
380,5,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
380,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
380,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
380,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,9,Eschar,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
380,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
380,11,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
380,12,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
380,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
380,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
380,15,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
380,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
381,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
381,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
381,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
381,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
381,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
381,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
382,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
382,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
383,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
384,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
384,2,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
384,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
384,4,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
384,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
384,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
385,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
386,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
387,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
388,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
388,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
388,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
388,4,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
388,5,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
388,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
388,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
389,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
389,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
389,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
389,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
389,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
389,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
389,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
389,9,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
389,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
389,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
389,12,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
389,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
390,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
391,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
391,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
392,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
392,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
392,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
392,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
392,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
393,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,4,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,5,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,6,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
393,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
393,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
393,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,13,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
393,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
394,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
394,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
395,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
396,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
397,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
398,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
398,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
398,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
399,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
399,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
400,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
400,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
400,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
401,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
401,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
401,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
401,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
401,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
402,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
403,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
403,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
404,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
405,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
406,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
407,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
407,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
407,3,Headache,Headaches NEC,Headaches,Nerv,N
407,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
407,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
407,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
407,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
408,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
408,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
408,3,Diffuse large B-cell lymphoma stage II,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
408,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
408,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
408,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
408,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
408,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
408,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
408,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
408,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
408,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
409,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
411,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
411,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
412,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
412,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
413,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
413,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
413,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
414,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
414,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
415,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
415,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
415,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
415,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
416,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
416,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
416,3,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
417,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
417,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
418,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
418,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
418,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
418,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
418,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
418,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
419,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
420,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
421,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
422,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
422,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
423,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
423,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
424,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
425,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
425,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
426,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
426,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
427,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
427,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
428,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
428,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
429,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
429,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
430,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
430,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
431,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
431,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
432,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
433,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
434,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
435,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
436,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
437,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
437,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
437,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
438,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
438,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
439,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
439,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
440,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
441,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
441,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
441,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
441,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
441,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
441,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
441,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
441,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
441,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
441,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
442,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
443,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
444,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
444,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
445,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
445,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
446,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
446,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
446,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
446,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
447,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
447,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
447,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
447,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
447,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
447,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
447,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
447,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
447,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
447,10,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
447,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
448,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
448,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
448,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
448,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
448,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
449,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
449,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
450,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
451,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
451,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
452,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
452,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
453,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
453,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
454,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
455,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
455,2,Anti-erythrocyte antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
456,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
456,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
456,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
456,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
456,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
456,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
456,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
457,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
457,2,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
457,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
457,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
458,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
458,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
459,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
460,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
461,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
461,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
462,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
462,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
463,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
463,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
463,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
463,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
463,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
463,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
463,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
464,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
464,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
465,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
465,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
465,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
466,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
466,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
466,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
467,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
467,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
467,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
468,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
468,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
469,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
469,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
469,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
470,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
470,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
471,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
471,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
471,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
471,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
471,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
471,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
472,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
472,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
473,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
473,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
473,3,Implant site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
473,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
474,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
474,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
474,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
475,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
475,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
475,3,Rickets,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
476,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
476,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
476,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
476,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
477,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
478,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
479,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
480,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
481,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
482,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
483,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
484,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
484,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
485,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
486,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
487,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
487,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
488,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
488,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
489,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
489,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
490,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
490,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
490,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
490,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
491,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
492,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
492,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
492,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
493,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
493,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
493,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
494,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
494,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
494,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
494,4,Laryngitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
494,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
494,6,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
494,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
496,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
496,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
497,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
498,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
498,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
498,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
498,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
498,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
498,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
498,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
498,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
498,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
498,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
498,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
498,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
499,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
499,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
500,1,Candida test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
500,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
500,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
500,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
500,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
500,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
500,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
500,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
500,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
501,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
502,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
502,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
502,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
503,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
503,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
504,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
504,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
504,3,Headache,Headaches NEC,Headaches,Nerv,N
504,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
504,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
504,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
505,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
505,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
506,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
506,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
506,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
506,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
506,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
507,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
508,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
509,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
509,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
510,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
510,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
511,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
511,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
511,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
511,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
511,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
511,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
512,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,3,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
513,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
514,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
514,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
515,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
516,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
516,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
516,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
517,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
517,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
517,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
517,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
517,5,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
517,6,Sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
517,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
517,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
518,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
519,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
519,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
519,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
520,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
521,1,Testicular neoplasm,Reproductive neoplasms male unspecified malignancy,Reproductive neoplasms male malignant and unspecified,Neopl,N
522,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
523,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
524,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
525,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
525,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
525,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
525,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
525,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
525,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
525,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
526,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
526,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
527,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
527,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
527,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
527,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
527,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
527,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
527,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
527,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
527,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
527,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
527,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
527,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
527,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
529,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
529,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
529,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
529,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
529,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
530,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
531,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
531,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
531,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
532,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
532,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
532,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
532,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
532,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
533,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
534,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
534,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
535,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
535,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
535,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
535,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
536,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
536,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
537,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
537,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
538,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
539,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
539,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
540,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
541,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
541,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
541,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
541,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
542,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
542,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
542,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
542,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
542,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
543,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
543,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
544,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
545,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
545,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
545,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
545,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
545,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
545,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
546,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
546,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
547,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
548,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
548,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
549,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
550,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
551,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
552,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
553,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
554,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
554,2,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
554,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
554,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
554,5,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
554,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
554,7,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
554,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
554,9,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
555,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
556,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
557,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
558,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
559,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
560,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
561,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
561,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
561,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
562,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
562,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
562,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
563,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
563,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
563,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
563,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
563,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
563,6,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
563,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
563,8,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
563,9,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
563,10,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
563,11,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
563,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
563,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
563,14,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
563,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
564,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
564,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
565,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
565,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
566,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
567,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
567,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
568,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
568,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
568,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
569,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
570,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
571,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
571,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
571,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
571,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
572,1,Ewing's sarcoma recurrent,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
573,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
573,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
574,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
575,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
575,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
576,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
576,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
577,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
577,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
577,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
578,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
578,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
579,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
579,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
580,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
580,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
581,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
581,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
582,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
582,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
582,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
582,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
582,5,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
582,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
583,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
584,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
585,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
585,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
586,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
586,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
587,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
587,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
588,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
588,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
588,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
588,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
588,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
589,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
590,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
590,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
591,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
591,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
592,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
593,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
594,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
594,2,Headache,Headaches NEC,Headaches,Nerv,N
594,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
594,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
595,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
595,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
596,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
596,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
596,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
597,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
597,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
597,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
598,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
598,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
599,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
599,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
600,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
600,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
600,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
601,1,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
602,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
602,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
602,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
603,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
603,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
603,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
603,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
603,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
603,6,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
603,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
603,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
603,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
603,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
603,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
603,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
603,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
604,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
604,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
604,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
605,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
605,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
606,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
607,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
607,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
608,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
608,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
608,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
609,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
610,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
611,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
612,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
613,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
614,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
615,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
616,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
617,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
618,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
618,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
619,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
619,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
619,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
620,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
620,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
620,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
620,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
620,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
620,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
621,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
621,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
622,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
622,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
622,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
622,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
622,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
622,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
623,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
624,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
625,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
625,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
625,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
625,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
625,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
625,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
625,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
626,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
627,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
627,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
627,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
627,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
628,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
628,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
628,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
628,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,6,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,Y
629,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
629,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
630,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
631,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
631,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
632,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
632,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
632,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
632,4,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
632,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
632,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
632,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
632,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
632,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
632,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
632,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
632,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
633,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
633,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
634,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
635,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
635,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
636,1,"Follicle centre lymphoma, follicular grade I, II, III recurrent",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
636,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
637,1,Catheter site erythema,Implant and catheter site reactions,Administration site reactions,Genrl,N
637,2,Catheter site pruritus,Implant and catheter site reactions,Administration site reactions,Genrl,N
637,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
637,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
638,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
638,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
639,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
639,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
639,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
639,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
639,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
639,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
640,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
640,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
640,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
641,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
641,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
641,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
641,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
642,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
643,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
644,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
645,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
646,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
646,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
647,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
648,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
648,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
648,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
649,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
650,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
650,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
650,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
650,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
650,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
650,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
650,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
650,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
650,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
651,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
652,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
652,2,Enzyme level increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
652,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
653,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
653,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
653,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
653,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
653,5,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
653,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
653,7,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
653,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
653,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
653,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
653,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,12,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
653,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
653,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
654,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
655,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
656,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
658,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
658,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
659,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
659,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
659,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
660,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
661,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
661,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
661,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
661,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
661,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
661,6,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
661,7,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
661,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,9,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
661,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
661,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
661,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
662,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
663,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
663,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
663,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
664,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
664,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
665,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
665,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
665,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
665,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
666,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
667,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
668,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
668,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
668,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
668,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
668,5,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
668,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,7,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
668,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
668,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
668,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
668,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
668,12,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
669,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
670,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
670,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
671,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
671,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
672,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
672,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
672,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
672,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
672,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
672,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
673,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
673,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
673,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
673,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
673,5,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
673,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
673,7,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
673,8,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
673,9,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
673,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
673,11,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
673,12,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
673,13,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
673,14,Murphy's sign positive,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
673,15,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
673,16,Ultrasound abdomen abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
673,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
674,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
674,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
674,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
675,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
675,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
676,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
676,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
677,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
677,2,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
677,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
678,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
678,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
678,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
678,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
678,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
679,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
679,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
679,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
679,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
680,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
681,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
681,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
681,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
682,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
683,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
684,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
684,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
684,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
685,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
686,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
686,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
687,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
687,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
688,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
689,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
690,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
690,2,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
690,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
690,4,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
690,5,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
690,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
691,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
691,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
691,3,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
691,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
691,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
691,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
691,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
691,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
691,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
691,10,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
692,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
692,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
692,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
692,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
692,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
692,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
692,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
692,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
692,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
692,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
692,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
693,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
694,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
695,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
695,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
696,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
697,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
697,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
698,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
698,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
698,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
698,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
698,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
698,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
698,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
698,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
698,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
698,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
698,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
699,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
699,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
700,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
702,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
703,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
703,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
703,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
703,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
704,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
705,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
705,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
705,3,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
705,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
705,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
705,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
705,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
705,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
706,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
706,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
706,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,4,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
706,5,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
707,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
707,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
707,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
707,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
707,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
707,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
708,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
708,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
709,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
710,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
710,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
710,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
710,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
710,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
710,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
710,7,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
710,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
711,2,Hereditary motor and sensory neuropathy,Peripheral nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
712,1,Glioneuronal tumour,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
712,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
713,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
713,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
714,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
715,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
716,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
716,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
717,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
717,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
718,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
719,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
719,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
719,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
719,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
719,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
720,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
721,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
722,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
722,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
722,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
723,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
724,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
725,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
725,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
725,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
726,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
726,2,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
727,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
727,2,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
728,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
728,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
729,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
729,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
730,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
730,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
730,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
731,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
731,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
732,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
732,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
733,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
733,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
734,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
735,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
736,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
737,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
737,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
737,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
737,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
737,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
738,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
739,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
739,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
739,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
739,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
739,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
740,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
740,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
742,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
743,1,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
744,1,Choluria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
744,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
744,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
744,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
744,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
745,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
745,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
746,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
746,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
747,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
747,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
747,3,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
748,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
748,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
748,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
748,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
748,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
748,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
748,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
749,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
749,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
750,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
750,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
750,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
750,4,Funnel chest acquired,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
750,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
750,6,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
750,7,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
750,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
750,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
750,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
751,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
752,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
752,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
753,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
754,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
756,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
756,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
756,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
756,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
756,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
756,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
756,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
756,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
757,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
758,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
758,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
758,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
759,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
760,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
760,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
761,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
762,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
762,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
762,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
762,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
762,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
763,1,B-cell lymphoma stage IV,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
763,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
763,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
764,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
764,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
765,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
765,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
766,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
766,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
766,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
766,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
766,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
766,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
766,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
767,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
768,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
768,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
768,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
768,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
769,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
769,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
769,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
769,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
769,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
771,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
771,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
772,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
772,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
772,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
772,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
773,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
774,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
774,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
774,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
774,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
774,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
774,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
774,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
774,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
774,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
774,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
774,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
774,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
774,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
774,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
774,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
775,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
776,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
776,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
776,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
776,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
777,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
777,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
777,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
777,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
777,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
778,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
778,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
779,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
779,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
779,3,Blast cells present,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
779,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
779,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
779,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
779,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
779,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
779,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
779,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
779,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
780,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
780,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
781,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
781,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
782,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
783,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
783,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,Y
783,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
784,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
784,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
784,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
785,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
786,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
786,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
786,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
787,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
788,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
788,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
788,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
789,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
789,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
790,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
790,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
790,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
791,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
791,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
792,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
793,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
794,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
795,1,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
796,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
796,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
796,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
796,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
797,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
798,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
798,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
798,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
798,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
798,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
798,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
799,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
800,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
801,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
801,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
802,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
803,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
803,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
803,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
803,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
803,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
804,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
804,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
805,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
806,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
806,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
806,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
806,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
806,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
806,6,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
806,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
807,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
808,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
808,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
808,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
809,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
809,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
809,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
810,1,Accidental death,Death and sudden death,Fatal outcomes,Genrl,Y
810,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
811,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
812,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
812,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
812,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
814,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
815,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
815,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
816,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
816,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
816,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
817,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
817,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
817,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
818,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
818,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
818,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
818,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
818,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
818,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
819,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
819,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
819,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
819,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
819,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
820,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
820,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
820,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
820,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
820,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
820,6,Histiocytic sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
820,7,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
820,8,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
820,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
820,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
821,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
821,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
821,3,Hepatosplenic candidiasis,Candida infections,Fungal infectious disorders,Infec,N
821,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
821,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
821,6,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
822,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
822,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
823,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
823,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
823,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
823,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
823,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
824,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
824,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
824,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
825,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
825,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
826,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
826,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
826,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
826,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
827,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
828,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
828,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
828,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
829,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
829,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
830,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
830,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
831,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
832,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
832,2,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
832,3,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
832,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
833,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
833,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
833,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
834,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
835,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
835,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
835,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
835,4,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
835,5,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
835,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
835,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
835,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
835,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
835,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
836,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
836,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
836,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
836,4,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
837,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
837,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
837,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
837,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
837,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
837,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
837,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
837,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
838,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
838,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
839,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
839,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
840,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
840,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
840,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
841,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
841,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
841,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
842,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
843,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
844,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
844,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
845,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
846,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
847,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
847,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
848,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
849,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
849,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
849,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
849,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
849,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
849,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
849,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
849,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
849,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
849,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
850,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
851,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
851,2,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
851,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
851,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
851,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
851,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
852,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
852,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
852,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
852,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
853,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
853,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
853,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
854,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
854,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
854,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
854,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
854,5,Purpura fulminans,Purpura and related conditions,Skin vascular abnormalities,Skin,N
854,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
855,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
855,2,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
855,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
855,4,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
855,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
855,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
855,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
855,8,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
855,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
856,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
857,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
858,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
858,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
859,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
859,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
859,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
859,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
860,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
860,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
860,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
860,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
861,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
861,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
862,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
862,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
862,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
862,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
863,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
863,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
864,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
865,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
865,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
865,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
866,1,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
867,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
868,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
868,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
868,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
868,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
868,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
868,6,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
868,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
868,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
868,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
869,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
870,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
871,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
872,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
872,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
872,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
872,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
873,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
873,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
874,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
874,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
874,3,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
874,4,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
874,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
875,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
876,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
876,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
876,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
876,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
877,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
877,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
877,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
877,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
878,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
879,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
880,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
881,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
881,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
882,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
882,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
882,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
883,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
884,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
884,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
884,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
885,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
886,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
886,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
887,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
887,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
888,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
888,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
889,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
889,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
889,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
889,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
889,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
889,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
889,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
889,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
890,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
890,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
891,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
892,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
893,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
894,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
894,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
896,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
897,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
898,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
899,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
902,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
903,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
904,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
905,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
905,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
905,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
905,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
907,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
907,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
907,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
907,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
907,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
907,6,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
908,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
908,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
908,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
909,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
909,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
910,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
910,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
910,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
910,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
911,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
912,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
912,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
912,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
912,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
913,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
913,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
913,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
913,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
913,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
913,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
913,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
913,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
913,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
914,1,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
914,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
914,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
915,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
915,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
915,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
916,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
916,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
916,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
916,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
916,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
916,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
916,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
916,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
916,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
917,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
917,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
917,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
918,1,Vagus nerve paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
918,2,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
919,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
919,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
920,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
920,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
921,1,Vagus nerve paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
922,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
922,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
923,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
923,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
923,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
924,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
924,2,Headache,Headaches NEC,Headaches,Nerv,N
924,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
924,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
924,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
925,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
926,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
927,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
928,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
929,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
929,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
930,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
930,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
931,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
931,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
932,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
933,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
934,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
935,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
936,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
937,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
938,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
939,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
940,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
941,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
942,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
943,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
944,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
945,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
946,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
947,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
948,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
949,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
950,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
951,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
952,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
953,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
954,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
955,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
956,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
957,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
958,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
959,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
960,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
961,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
962,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
963,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
964,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
965,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
966,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
967,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
968,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
969,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
970,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
971,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
972,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
973,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
974,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
975,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
976,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
977,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
978,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
979,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
980,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
981,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
982,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
983,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
984,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
985,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
986,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
987,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
988,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
989,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
990,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
991,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
992,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
993,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
994,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
995,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
996,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
997,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
998,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
999,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1000,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1001,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1002,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1003,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1004,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1005,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1006,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1007,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1008,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1009,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1010,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1011,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1012,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1013,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1014,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1015,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1016,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1017,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1018,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1019,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1020,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1021,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1022,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1023,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1024,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1025,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1026,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1027,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1028,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1029,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1030,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1031,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1032,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1033,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1034,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1035,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1036,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1037,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1038,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1039,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1040,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1041,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1042,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1043,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1044,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1045,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1046,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1047,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1048,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1049,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1050,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1051,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1052,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1053,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1054,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1055,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1056,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1057,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1058,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1059,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1060,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1061,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1062,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1063,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1064,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1065,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1066,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1067,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1068,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1069,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1070,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1071,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1071,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1071,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1071,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1071,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1071,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1072,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1073,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1074,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1075,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1076,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1077,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1078,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1079,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1080,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1081,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1082,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1084,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1085,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1086,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1087,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1088,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1089,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1090,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1091,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1092,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1093,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1094,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1095,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1096,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1097,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1098,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1099,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1100,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1101,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1102,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1103,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1104,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1105,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1106,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1107,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1108,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1109,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1110,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1111,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1112,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1113,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1114,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1115,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1116,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1117,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1118,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1119,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1120,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1121,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1122,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1123,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1123,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1123,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1123,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1123,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1123,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1123,7,Headache,Headaches NEC,Headaches,Nerv,N
1123,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1123,9,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1123,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1123,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1123,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1123,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1123,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1123,15,Rectal prolapse,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1123,16,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1123,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1124,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1124,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1124,3,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1124,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1124,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1125,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1125,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1126,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1126,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1126,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1127,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1127,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1128,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1129,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1129,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1129,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1129,4,Placenta accreta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1129,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1130,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1130,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1130,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1130,4,Positive airway pressure therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1130,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1131,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1131,2,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1131,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1132,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1132,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1132,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1132,5,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
1132,6,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1133,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1133,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1134,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1135,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1135,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1135,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1136,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1136,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1136,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1136,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1136,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1136,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1137,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1137,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1138,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1138,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1138,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1138,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
1139,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1140,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
1141,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1141,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1141,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1141,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1141,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1141,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1142,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1143,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1143,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1143,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1144,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1145,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1145,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1145,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1145,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1145,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1145,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1145,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1145,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1145,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1145,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1145,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1145,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1145,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1145,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1146,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1146,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1147,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1147,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1147,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1148,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1148,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1148,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1148,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1149,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1149,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1150,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1151,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1151,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1152,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1152,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1153,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1153,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1153,3,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1153,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1153,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1153,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1153,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1153,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1154,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1155,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1156,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1157,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1157,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1157,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1157,4,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1158,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1158,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1158,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1158,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1158,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1158,6,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1159,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1159,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1159,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1159,4,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1160,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1160,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1160,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1160,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1160,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1160,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1160,7,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1160,8,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1161,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1161,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1161,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1161,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1161,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1161,7,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1161,8,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1162,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1162,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1162,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1162,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1162,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1162,6,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1162,7,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1163,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1163,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1163,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1163,4,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1164,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1164,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1165,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1166,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1167,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1167,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
1168,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1168,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1168,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1168,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1168,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1168,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1169,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1170,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1171,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1172,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1173,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1174,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1175,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1176,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1177,1,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1178,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1179,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1179,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1180,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1180,2,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1181,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1181,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1181,3,Headache,Headaches NEC,Headaches,Nerv,N
1181,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1181,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1181,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1181,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1182,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1183,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1184,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1184,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1184,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1185,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1185,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1185,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1186,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1187,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
1187,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1187,3,West Nile viral infection,Flaviviral infections,Viral infectious disorders,Infec,N
1188,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1189,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1189,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1189,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1190,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1191,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
1191,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1191,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1191,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1191,5,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1191,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1192,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
1192,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1192,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1192,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1193,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1193,2,Headache,Headaches NEC,Headaches,Nerv,N
1194,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1194,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1195,1,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1196,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1196,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1196,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1196,4,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1196,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,6,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,7,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1196,8,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1196,9,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1196,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1196,11,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1196,12,Death,Death and sudden death,Fatal outcomes,Genrl,N
1196,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1196,14,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,15,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,16,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,17,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1196,18,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1196,19,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1196,20,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
1196,21,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1196,22,Headache,Headaches NEC,Headaches,Nerv,N
1196,23,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1196,24,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,25,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1196,26,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1196,27,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1196,28,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1196,29,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,30,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1196,31,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1196,32,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1196,33,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,34,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1196,35,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1196,36,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1196,37,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1197,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1197,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1198,1,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1198,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1199,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1199,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1200,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1200,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1201,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1201,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1202,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1203,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1204,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1205,1,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1205,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1205,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1205,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1205,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1206,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1207,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1208,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1208,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1208,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1209,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1209,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1210,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1210,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
1211,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1211,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1211,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1211,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1211,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1212,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1212,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1212,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1212,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1212,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1212,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1212,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1212,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1213,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1214,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1214,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1214,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1214,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1214,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1214,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1214,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1214,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1215,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1215,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1215,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1215,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1215,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1215,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1215,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1215,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1215,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1215,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1216,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1216,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1216,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1216,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1216,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1216,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1216,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1216,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1216,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1216,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1216,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1216,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1216,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1216,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1216,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1216,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1217,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1217,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1217,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1217,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1217,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1217,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1218,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1219,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1220,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1220,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1221,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1221,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1221,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1221,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1222,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1222,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1222,3,Periventricular leukomalacia,Encephalopathies NEC,Encephalopathies,Nerv,Y
1223,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1223,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1224,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1224,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1225,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1226,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1227,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1227,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1227,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1227,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1227,5,Hepatosplenic candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1227,6,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1227,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1227,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1228,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
1229,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1229,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1229,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1229,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1229,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1229,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1230,1,Clonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1230,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1230,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1230,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1231,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1231,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1232,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1232,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1233,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1233,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1233,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1233,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1233,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1234,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1234,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1235,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1236,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1237,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1238,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1238,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1238,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1238,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1238,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1238,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1239,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1240,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1241,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1242,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1243,1,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1243,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1244,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1244,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1244,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1244,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1244,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1244,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1244,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1245,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1245,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1247,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1247,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1248,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1248,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1248,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1249,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1249,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1249,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1250,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1250,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1250,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1250,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1250,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1251,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1251,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1251,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1251,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
1251,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1252,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1252,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1252,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1252,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1253,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1253,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1254,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1255,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1256,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1256,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1256,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1257,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1258,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1258,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1259,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1260,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1260,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1261,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1261,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1261,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1261,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1261,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1261,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1261,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1262,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1263,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1263,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1264,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1265,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1266,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1267,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1267,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1268,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1268,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1268,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1269,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1269,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1270,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1271,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1271,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1272,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1272,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1272,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1272,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1273,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1273,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1274,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1274,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1275,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1276,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1276,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1276,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1276,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1276,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1276,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1276,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1276,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1277,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1278,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1278,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1280,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1280,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1281,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1282,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1283,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1284,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1285,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1285,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1286,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1286,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1287,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1287,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1288,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1288,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1289,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1290,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1290,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1291,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1291,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1291,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1291,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1291,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1291,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1291,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1291,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1291,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1292,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1293,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1294,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1294,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1295,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1296,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1297,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1297,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1298,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1299,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1300,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1300,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1301,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1301,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1301,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1301,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1301,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1301,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1301,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1302,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1302,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1302,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1303,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1304,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1305,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1306,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1306,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1307,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1308,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1308,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1308,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1309,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1310,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1310,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1311,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1311,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1311,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1311,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1312,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1313,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1314,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1314,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1315,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1316,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1317,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1318,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1318,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1318,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1318,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
1318,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1319,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1319,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1319,3,Perineal necrosis,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1319,4,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1319,5,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1320,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1321,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1322,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1322,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1323,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1324,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1324,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1325,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1325,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1326,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1327,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1328,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1329,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1329,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1329,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1330,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1330,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1331,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1332,1,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1333,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1333,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1334,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
1334,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1334,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1334,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1334,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1334,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1334,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1335,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1335,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1336,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1336,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1336,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1338,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1339,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1339,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1339,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1340,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1341,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1342,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1343,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1344,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1346,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1346,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1347,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1347,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1350,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1352,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1352,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1353,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1353,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1354,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1354,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1354,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1354,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1354,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1354,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1354,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1354,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1354,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1354,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1355,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1355,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,3,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1355,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1355,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1355,6,Headache,Headaches NEC,Headaches,Nerv,N
1355,7,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1355,8,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1355,9,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
1355,10,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1355,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1355,12,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1355,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1355,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1355,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1355,16,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1356,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1356,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1357,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1358,1,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1359,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1359,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1359,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1359,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1359,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1359,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1359,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1359,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1360,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1360,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1361,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1362,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1363,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1364,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1364,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1365,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1365,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1365,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1365,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1365,5,Headache,Headaches NEC,Headaches,Nerv,N
1365,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1365,7,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1365,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1365,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1365,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1365,11,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1365,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1365,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1365,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1366,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1366,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1367,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1367,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1367,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1368,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1368,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1369,1,Vocal cord paresis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1370,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1371,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1371,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1371,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1371,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1372,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1372,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1373,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1373,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1373,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1374,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1374,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
